Drug intelligence / Profile preview

Hand-Foot-Mouth Disease Vaccine (Vabiotech)

Development stage: Preclinical
Lead developer: Sinovac Biotech
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Hand-Foot-Mouth Disease Vaccine (Vabiotech) is a prophylactic vaccine candidate being developed or transferred by Vabiotech (Company of Vaccine and Biological Production No.1) in Vietnam. The vaccine is intended to prevent Hand, Foot, and Mouth Disease (HFMD) by eliciting protective immunity against the causative enteroviruses, such as Enterovirus 71 (EV71) and Coxsackievirus A16. As of 2024, the project is part of Vabiotech's technology transfer and research and development pipeline, aimed at establishing local production or distribution capabilities for HFMD prevention in the Vietnamese market.

Other names: Vắc xin phòng bệnh tay, chân, miệngHand-Foot-Mouth Disease Vaccine

Beyond the preview

Go deeper on Hand-Foot-Mouth Disease Vaccine (Vabiotech).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hand-Foot-Mouth Disease Vaccine (Vabiotech).

Explore the full profile